Intended for healthcare professionals

Rapid response to:

Feature

Should patient groups accept money from drug companies? No

BMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39185.394005.AD (Published 03 May 2007) Cite this as: BMJ 2007;334:935

Rapid Response:

response from Cancerbackup

Dear Sirs

In response to Barbara Mintzes comments, should patient groups accept
money from drug companies? (May 4th) that Cancerbackup does not list the
possible side effects of trastuzumab, or say where our funding comes from
– this is not the case.

First, Cancerbackup provides up to date and accurate information
about treatment including all possible side effects, both on our website
and in our factsheets.

Secondly, we provide a full list on our website and now in our press
releases of all funders.

We are advised by an independent Clinical Advisory Board.
Pharmaceutical companies have no influence on any decision we take.

Yours faithfully

Joanne Rule


Cancerbackup Chief Executive

Competing interests:
None declared

Competing interests: No competing interests

04 May 2007
Joanne Rule
Cancerbackup Chief Executive
Cancerbackup EC2A 3JR